Cleared Traditional

TOTAL CROSS .021 PERCUT. TRANSLUMINAL ANGIO. CATH. (K921856) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K921856 · Schneider Intl., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
95d
Days
Class 2
Risk

K921856 is an FDA 510(k) clearance for the TOTAL CROSS .021 PERCUT. TRANSLUMINAL ANGIO. CATH.. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Schneider Intl., Ltd. (Plymouth, US). The FDA issued a Cleared decision on July 21, 1992 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Schneider Intl., Ltd. devices

Submission Details

510(k) Number K921856 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 1992
Decision Date July 21, 1992
Days to Decision 95 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 125d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 152
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K921856.
BALLOON DILATATION CATHETER
K922610 · Boston Scientific Corp · Nov 1992
SHORT TEGWIRE -- MODIFIED
K924276 · Boston Scientific Corp · Nov 1992
SUB-4 SMALL VESSEL BALLOON DILATATION CATHETER
K924047 · Boston Scientific Corp · Nov 1992
ULTRA-THIN
K920547 · Boston Scientific Corp · May 1992
TEGWIRE (TM)
K913391 · Boston Scientific Corp · Nov 1991
SUB-4(TM), PERIPHERAL DILATATION CATHETER
K913689 · Boston Scientific Corp · Oct 1991